Eleanor L. Wright is a notable inventor based in Earlysville, Virginia. She has made significant contributions to the field of biomedical engineering, particularly in the area of immunology. With a total of 2 patents, her work focuses on innovative methods to enhance the efficacy of treatments involving red blood cells.

Latest Patents

Eleanor's latest patents include a groundbreaking invention titled "Mammalian primate erythrocyte bound heteropolymerized monoclonal." This invention utilizes mammalian red blood cells to safely and rapidly neutralize and clear antigens or immunogens from the circulatory system. The process involves binding a monoclonal antibody specific for a receptor (CR1) on the red blood cells. This monoclonal antibody is chemically bound to a second monoclonal antibody that targets the antigen to be cleared. These chemically cross-linked monoclonal antibody heteropolymers can be injected directly into the patient's circulatory system. Alternatively, red blood cells extracted from the patient or provided by a suitable donor can be bound to the monoclonal antibody complex and returned to the system.

Career Highlights

Eleanor L. Wright is affiliated with the University of Virginia Patent Foundation, where she continues to advance her research and innovations. Her work has garnered attention for its potential applications in medical treatments and therapies.

Collaborations

Eleanor has collaborated with esteemed colleagues, including Ronald P. Taylor and William M. Sutherland. These partnerships have contributed to the development and refinement of her innovative ideas.

Conclusion

Eleanor L. Wright's contributions to the field of immunology through her patents and research at the University of Virginia Patent Foundation highlight her role as a pioneering inventor. Her innovative approaches to utilizing red blood cells for therapeutic purposes demonstrate the potential for significant advancements in medical science.